Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|July 14, 2025
Intratumoral amino acid insufficiency limits CD8+ T-cell effector functionYan-Ting Chen, Ya-Hui Lin, Jahan Rahman, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 24, 2020
Spectroscopic and molecular modelling study of binding mechanism of bovine serum albumin with phosmetAfreen Jahan Rahman, Deepti Sharma, Deepanshu Kumar, et al.Microbiome|June 17, 2023
CRISPR arrays as high-resolution markers to track microbial transmission during influenza infectionLingdi Zhang, Jahan Rahman, Matthew Chung, et al.Journal of Biomolecular Structure & Dynamics|February 28, 2022
Luminescence studies of binding affinity of vildagliptin with bovine serum albuminPiyush Verma, Lajpreet Kaur, Priyanka Aswal, et al.Research Square|June 17, 2024
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.Biorxiv : the Preprint Server for Biology|July 14, 2025
MEK-dependent bioenergetic demand drives terminal CD8 + T cell exhaustionTanmana Mitra, Jahan Rahman, Madeline Hwee, et al.Immunity|July 13, 2026
MEK-dependent bioenergetic demand drives terminal CD8+ T cell exhaustionTanmana Mitra, Jahan Rahman, Madeline Hwee, et al.Frontiers in Immunology|April 18, 2025
Case Report: Decentralized trial of tolerability-adapted exercise therapy after severe Covid-19Jessica M Scott, Zhuyu Qiu, Jahan Rahman, et al.Biorxiv : the Preprint Server for Biology|January 8, 2024
Covalent Targeting of Splicing in T CellsKevin A Scott, Hiroyuki Kojima, Nathalie Ropek, et al.Cancer Cell|August 15, 2025
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.Pageof 3